GTx Company Profile (NASDAQ:GTXI)

About GTx

GTx logoGTx, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other medical conditions. The Company is engaged in the development of selective androgen receptor modulators (SARMs). Its lead product candidate, enobosarm (GTx-024), had been evaluated in over 24 completed or ongoing clinical trials, including in approximately six Phase II and two Phase III clinical trials. The Company is also engaged in the development of GTx-758 (Capesaris), an oral nonsteroidal selective estrogen receptor alpha agonist, for secondary hormonal therapy in men with metastatic and high-risk non-metastatic castration resistant prostate cancer (CRPC). Its product candidate, Enobosarm, for the treatment of women with advanced androgen receptor (AR) positive triple-negative breast cancer (TNBC), is in Phase II clinical development-stage.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: GTXI
  • CUSIP: 40052B10
Key Metrics:
  • Previous Close: $0.84
  • 50 Day Moving Average: $0.793
  • 200 Day Moving Average: $0.672
  • 52-Week Range: $0.29 - $1.14
  • Trailing P/E Ratio: 5.072
  • Foreward P/E Ratio: -7.02
  • P/E Growth: 0.000
  • Market Cap: $119.49M
  • Outstanding Shares: 141,915,000
  • Beta: 2.36
  • Return on Equity: 138.84%
  • Return on Assets: 56.58%
  • Current Ratio: 6.18%
  • Quick Ratio: 6.18%
Additional Links:
Companies Related to GTx:

Analyst Ratings

Consensus Ratings for GTx (NASDAQ:GTXI) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.00 (18.76% upside)

Analysts' Ratings History for GTx (NASDAQ:GTXI)
DateFirmActionRatingPrice TargetDetails
9/9/2016Jefferies GroupReiterated RatingHold$1.00View Rating Details
(Data available from 10/26/2014 forward)


Earnings History for GTx (NASDAQ:GTXI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016($0.05)N/AView Earnings Details
8/9/2016Q2($0.05)($0.04)ViewN/AView Earnings Details
5/10/2016Q1($0.04)$0.01ViewN/AView Earnings Details
3/3/2016Q415($0.10)($0.04)ViewListenView Earnings Details
10/29/2015Q315($0.06)($0.04)ViewListenView Earnings Details
8/6/2015Q215($0.04)($0.34)ViewListenView Earnings Details
5/8/2015Q1($0.04)($0.04)ViewListenView Earnings Details
3/4/2015Q314($0.07)($0.05)ViewListenView Earnings Details
11/10/2014Q214($0.11)($0.06)ViewListenView Earnings Details
8/5/2014Q2($0.12)($0.15)ViewN/AView Earnings Details
5/8/2014Q114($0.12)($0.14)ViewN/AView Earnings Details
3/4/2014Q413($0.13)($0.12)ViewListenView Earnings Details
11/12/2013Q313($0.21)($0.14)ViewListenView Earnings Details
7/19/2013Q2 2013($0.22)($0.20)ViewN/AView Earnings Details
5/3/2013Q1 2013($0.21)($0.20)ViewListenView Earnings Details
2/21/2013Q4 2012($0.21)($0.17)ViewListenView Earnings Details
11/8/2012Q312($0.17)$0.12$1.93 millionViewN/AView Earnings Details
8/8/2012($0.17)($0.17)ViewN/AView Earnings Details
5/8/2012($0.17)($0.18)ViewN/AView Earnings Details
2/21/2012($0.17)($0.17)ViewN/AView Earnings Details
11/4/2011($0.18)($0.15)ViewN/AView Earnings Details
8/9/2011($0.19)($0.21)ViewN/AView Earnings Details
5/9/2011($0.13)($0.05)ViewN/AView Earnings Details
2/24/2011($0.16)($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for GTx (NASDAQ:GTXI)
Current Year EPS Consensus Estimate: $-0.12 EPS
Next Year EPS Consensus Estimate: $-0.12 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.04)($0.04)($0.04)
Q2 20161($0.05)($0.05)($0.05)
Q3 20161($0.05)($0.05)($0.05)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)


Dividend History for GTx (NASDAQ:GTXI)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for GTx (NASDAQ:GTXI)
Insider Ownership Percentage: 40.60%
Institutional Ownership Percentage: 9.62%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/14/2016Peak Foundation PyramidMajor ShareholderBuy7,716,049$0.81$6,249,999.69View SEC Filing  
6/16/2016Robert James WillsChairmanBuy100,000$0.65$65,000.00View SEC Filing  
3/1/2016J Kenneth GlassDirectorBuy44,000$0.60$26,400.00View SEC Filing  
1/26/2016Marc Steven HanoverCEOBuy4,000$0.65$2,600.00View SEC Filing  
1/25/2016Marc Steven HanoverCEOBuy12,813$0.63$8,072.19View SEC Filing  
1/19/2016Marc Steven HanoverCEOBuy25,000$0.50$12,500.00View SEC Filing  
1/14/2016Marc Steven HanoverCEOBuy25,000$0.49$12,250.00View SEC Filing  
12/24/2015J Kenneth GlassDirectorBuy100$0.79$79.00View SEC Filing  
12/22/2015J Kenneth GlassDirectorBuy1,907$0.78$1,487.46View SEC Filing  
12/21/2015J Kenneth GlassDirectorBuy39,900$0.78$31,122.00View SEC Filing  
5/19/2015J Kenneth GlassDirectorBuy24,500$1.25$30,625.00View SEC Filing  
5/14/2015Robert James WillsChairmanBuy46,140$0.96$44,294.40View SEC Filing  
5/8/2015Henry Patton DoggrellVPBuy25,477$0.80$20,381.60View SEC Filing  
5/8/2015Robert James WillsChairmanBuy50,000$0.80$40,000.00View SEC Filing  
4/22/2015J Kenneth GlassDirectorBuy10,000$0.72$7,200.00View SEC Filing  
4/21/2015J Kenneth GlassDirectorBuy11,608$0.71$8,241.68View SEC Filing  
4/15/2015J Kenneth GlassDirectorBuy3,300$0.72$2,376.00View SEC Filing  
4/10/2015J Kenneth GlassDirectorBuy16,400$0.67$10,988.00View SEC Filing  
9/23/2014Marc Steven HanoverCEOBuy5,000$0.75$3,750.00View SEC Filing  
9/17/2014Marc Steven HanoverCEOBuy10,000$0.74$7,400.00View SEC Filing  
8/21/2014Marc Steven HanoverCEOBuy20,000$1.00$20,000.00View SEC Filing  
8/19/2014Marc Steven HanoverCEOBuy10,000$1.01$10,100.00View SEC Filing  
8/8/2014Henry Patton DoggrellVPBuy10,000$0.97$9,700.00View SEC Filing  
8/8/2014Marc Steven HanoverCEOBuy30,000$0.93$27,900.00View SEC Filing  
8/7/2014Jason T ShackelfordInsiderBuy10,000$0.92$9,200.00View SEC Filing  
8/7/2014Marc Steven HanoverCEOBuy30,000$0.92$27,600.00View SEC Filing  
6/6/2014James T DaltonVPSell72,883$1.30$94,747.90View SEC Filing  
3/21/2014Jack Schulermajor shareholderSell1,192,251$1.84$2,193,741.84View SEC Filing  
8/22/2013Jack Schulermajor shareholderBuy93,777$1.36$127,536.72View SEC Filing  
8/21/2013Jack Schulermajor shareholderBuy309,591$1.42$439,619.22View SEC Filing  
7/9/2013Mark Edward MostellerCFOSell17,000$6.99$118,830.00View SEC Filing  
1/17/2013James T DaltonVPSell20,000$5.20$104,000.00View SEC Filing  
12/14/2012Timothy R G SearDirectorBuy50,000$4.33$216,500.00View SEC Filing  
8/27/2012J Kenneth GlassDirectorBuy10,000$3.76$37,600.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for GTx (NASDAQ:GTXI)
DateHeadline logoBIOSTAR Announces VR-Ready and Gaming Solution with its GTX 1060 Graphics Card with Dual-Fan Design - Designed for your First VR Gaming Rig (NASDAQ:GTXI) - October 25 at 10:17 AM logoDiscover GeForce PC Gaming: NVIDIA Introduces GeForce GTX 1050 and 1050 Ti (NASDAQ:GTXI) - October 18 at 10:22 AM logoGIGABYTE Introduces GeForce® GTX 1050 Ti and GTX 1050 Graphics Card Lines (NASDAQ:GTXI) - October 18 at 10:22 AM logoGIGABYTE Unveils GeForce® GTX 1080 XTREME GAMING WATERFORCE WB with ... (NASDAQ:GTXI) - October 17 at 10:22 AM logoGTX INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial Cond (NASDAQ:GTXI) - October 12 at 10:22 AM logoGTx Announces $14.0 Million Registered Direct Common Stock Offering (NASDAQ:GTXI) - October 12 at 10:22 AM logoGIGABYTE Releases GeForce® GTX 1080 Graphics Card Turbo OC Edition with ... (NASDAQ:GTXI) - October 5 at 10:32 AM logoGlobal Capnography Market Technology, Applications, Key Players, Industry Insights, Outlook Report to 2027 (NASDAQ:GTXI) - September 30 at 10:29 AM logoGTx, Inc. (GTXI) Completes Stage 1 Milestone in Phase 2 Trial of Enobosarm in ER+/AR+ Breast Cancer (NASDAQ:GTXI) - September 8 at 5:15 PM logoGTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:GTXI) - September 8 at 5:15 PM logoGTx Achieves Stage 1 Milestone in Phase 2 Clinical Trial of Enobosarm in ER+/AR+ Breast Cancer (NASDAQ:GTXI) - September 8 at 9:12 AM logo7:02 am GTX achieves the Stage 1 milestone for the 9 mg cohort of its Phase 2 clinical trial of enobosarm to treat women with breast cancer; advances to stage 2 of trial (NASDAQ:GTXI) - September 8 at 9:12 AM logoBIOSTAR Expands Range of VR Gaming Ready Products with GeForce GTX 1070 Graphics Card - More BIOSTAR graphics card options to experience Virtual Reality and Ultra High-Definition Games (NASDAQ:GTXI) - September 6 at 10:05 AM logoGTx Announces Webcast of Corporate Presentation at Baird’s 2016 Healthcare Conference (NASDAQ:GTXI) - September 2 at 10:10 AM logoBRIEF-GTX Inc says size of board increased to seven directors from six - SEC filing (NASDAQ:GTXI) - September 1 at 5:12 PM
News IconGTx, Inc. Appoints To Board Of Directors (NASDAQ:GTXI) - September 1 at 5:12 PM logoGTx Appoints Dr. Garry Neil to Board of Directors (NASDAQ:GTXI) - September 1 at 8:15 AM logoGTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:GTXI) - September 1 at 8:15 AM logoGIGABYTE Releases GeForce® GTX 1060 XTREME GAMING 6GB Graphics Card (NASDAQ:GTXI) - August 23 at 9:44 AM logoGTX INC /DE/ Financials (NASDAQ:GTXI) - August 19 at 5:17 PM logoGIGABYTE Releases GeForce® GTX 1060 Graphics Cards Equipped with 3GB Memory (NASDAQ:GTXI) - August 18 at 5:22 PM logoGIGABYTE Introduces the GeForce® GTX 10 Series Gaming Laptops (NASDAQ:GTXI) - August 16 at 8:43 AM logoNvidia: 'GTX1080′ Will Power Them to Blow Away Q2 Estimate, Says M Science (NASDAQ:GTXI) - August 11 at 5:34 PM
News IconMemphis-based GTx posts $6 million loss (NASDAQ:GTXI) - August 10 at 12:47 PM
News IconGTx, Inc. Provides Corporate Update And Reports Second Quarter 2016 Financial Results (NASDAQ:GTXI) - August 10 at 12:47 PM logoGTx Provides Corporate Update and Reports Second Quarter 2016 Financial Results (NASDAQ:GTXI) - August 9 at 8:18 AM logoGTx reports 2Q loss (NASDAQ:GTXI) - August 9 at 8:18 AM logoGTx Inc.: GTx Provides Corporate Update and Reports Second Quarter 2016 Financial Results (NASDAQ:GTXI) - August 9 at 8:18 AM logoGTx beats by $0.01 (NASDAQ:GTXI) - August 9 at 7:16 AM logoGIGABYTE to Release GeForce® GTX 1060 G1 GAMING Graphics Card (NASDAQ:GTXI) - July 7 at 9:31 AM logoGIGABYTE Adds Two New Models to GeForce® GTX 1070 Line (NASDAQ:GTXI) - July 7 at 2:21 AM logoGIGABYTE Releases GeForce® GTX 1070 XTREME GAMING Graphics Card (NASDAQ:GTXI) - July 1 at 10:21 AM logoGTX INC /DE/ : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) (NASDAQ:GTXI) - June 22 at 5:27 PM logoGTX INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran (NASDAQ:GTXI) - June 22 at 10:01 AM
News IconGTx, Inc Therapeutics Drugs and Companies Pipeline Review H1 2016 Research Report (NASDAQ:GTXI) - June 22 at 9:59 AM logoGTx (GTXI) Shows Strength: Stock Adds 11.2% in Session (NASDAQ:GTXI) - June 21 at 8:15 AM logoForm 4 GTX INC /DE/ For: Jun 16 Filed by: Wills Robert James (NASDAQ:GTXI) - June 20 at 11:34 AM logoGIGABYTE Releases GeForce® GTX 1070 G1 GAMING Graphics Card (NASDAQ:GTXI) - June 17 at 2:29 AM logoGTx, Inc. :GTXI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 (NASDAQ:GTXI) - June 8 at 6:07 PM logoGIGABYTE Launches GeForce® GTX 1080 XTREME GAMING Graphics Card (NASDAQ:GTXI) - June 7 at 10:28 AM
News IconGTx, Inc. Pipeline Review, Industry Analysis, Market Size and Forecast 2016 to 2020 (NASDAQ:GTXI) - June 2 at 11:30 PM logoGTx Announces Webcast of Corporate Presentation at Jefferies 2016 Global Healthcare Conference (NASDAQ:GTXI) - June 2 at 7:15 AM logoCritics Call GeForce GTX 1070 “One Hell of a Graphics Card,” “Major Value,” “Significant Leap” (NASDAQ:GTXI) - May 31 at 10:52 AM
News IconGtx Incorporated (NASDAQ:GTXI) Sellers Covered 15.99% of Their Shorts - HNN (NASDAQ:GTXI) - May 29 at 2:20 PM logoToday's Watch List: Curis, Inc. (NASDAQ:CRIS), Innocoll Holdings plc (NASDAQ:INNL), Guidewire Software, Inc ... - KC Register (NASDAQ:GTXI) - May 27 at 2:53 PM logoGTx, Inc. (NASDAQ:GTXI) Quarterly EPS From Continuing Operations Stands At $0.0149 - Investor Newswire (NASDAQ:GTXI) - May 24 at 2:43 PM logoGTx Announces Webcast of Corporate Presentation at the UBS Global Healthcare Conference 2016 (NASDAQ:GTXI) - May 16 at 7:00 AM logoGTx Inc.: GTx Provides Corporate Update and Reports First Quarter 2016 Financial Results (NASDAQ:GTXI) - May 11 at 8:03 AM logoGTx posts 1Q profit (NASDAQ:GTXI) - May 10 at 7:14 AM logoQ1 2016 GTX Inc Earnings Release - Before Market Open (NASDAQ:GTXI) - May 10 at 7:07 AM


GTx (NASDAQ:GTXI) Chart for Wednesday, October, 26, 2016

Last Updated on 10/26/2016 by Staff